Prabhudas Lilladher recommended accumulate rating on Zydus Lifesciences with a target price of Rs 970 in its research report ...

ICICI Securities recommended hold rating on Zydus Lifesciences with a target price of Rs 910 in its research report dated May ...

Zydus Lifesciences Q4 stuns with margin guidance, but brokerages trim targets — stock ends at Rs 890. Should you follow ...

Zydus Lifesciences is on analysts' radar. The stock rose nearly 2% on Wednesday after reporting mixed fourth-quarter results.

Morgan Stanley believes India's fundamentals remain strong, supported by macro stability, improving terms of trade, declining ...

We are looking at what kind of products, diagnostics or other solutions we can offer to become a well-rounded player in a ...

Ahmedabad-based Zydus Lifesciences Ltd has registered a decline of around 1% in net profit at Rs. 1,170.9 crore during the last quarter of FY25, as compared to Rs. 1,182.3 crore in the same period a ...

Zydus Lifesciences Ltd. reported growth in the fourth quarter of fiscal 2025, driven by higher non-recurring components in ...

Shares of Hindalco, EIH, Zydus Lifesciences and Dixon Technologies will remain in focus as companies are set to post their Q4 ...

Dr. Reddy's Laboratories Ltd., Hindalco Industries Ltd. and Sun Pharmaceutical Industries were top three gainers in the Nifty ...

The Coalition for Global Hepatitis Elimination's National Hepatitis Elimination Profiles assess the status of national data, ...